The selective P-TEFb inhibitor CAN508 targets angiogenesis.

Vladimír Kryštof; Lucie Rárová; Johanna Liebl; Stefan Zahler; Radek Jorda; Jiří Voller; Petr Cankař

doi:10.1016/j.ejmech.2011.06.035

The selective P-TEFb inhibitor CAN508 targets angiogenesis.

Vladimír Kryštof, Lucie Rárová, Johanna Liebl, Stefan Zahler, Radek Jorda, Jiří Voller, Petr Cankař

Research output: Contribution to journal › Original Article › peer-review

29 Citations (Web of Science)

Original language	English
Pages (from-to)	428-494
Journal	EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume	46
Issue number	9
DOIs	https://doi.org/10.1016/j.ejmech.2011.06.035
Publication status	Published - 2011

Keywords

ENDOTHELIAL GROWTH-FACTOR
I-KAPPA-B
KINASE INHIBITOR
CELL-MIGRATION
CYCLIN D1
FACTOR EXPRESSION
CANCER-THERAPY
P53
ROSCOVITINE
FLAVOPIRIDOL

Access to Document

10.1016/j.ejmech.2011.06.035

Cite this

Kryštof, V., Rárová, L., Liebl, J., Zahler, S., Jorda, R., Voller, J., & Cankař, P. (2011). The selective P-TEFb inhibitor CAN508 targets angiogenesis. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , 46(9), 428-494. https://doi.org/10.1016/j.ejmech.2011.06.035

Kryštof, Vladimír ; Rárová, Lucie ; Liebl, Johanna et al. / The selective P-TEFb inhibitor CAN508 targets angiogenesis. In: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2011 ; Vol. 46, No. 9. pp. 428-494.

@article{c9ac0872bec945409cb1ec46b360bafe,

title = "The selective P-TEFb inhibitor CAN508 targets angiogenesis.",

keywords = "ENDOTHELIAL GROWTH-FACTOR, I-KAPPA-B, KINASE INHIBITOR, CELL-MIGRATION, CYCLIN D1, FACTOR EXPRESSION, CANCER-THERAPY, P53, ROSCOVITINE, FLAVOPIRIDOL",

author = "Vladim{\'i}r Kry{\v s}tof and Lucie R{\'a}rov{\'a} and Johanna Liebl and Stefan Zahler and Radek Jorda and Ji{\v r}{\'i} Voller and Petr Canka{\v r}",

year = "2011",

doi = "10.1016/j.ejmech.2011.06.035",

language = "English",

volume = "46",

pages = "428--494",

journal = "EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY ",

issn = "0223-5234",

number = "9",

}

Kryštof, V, Rárová, L, Liebl, J, Zahler, S, Jorda, R, Voller, J & Cankař, P 2011, 'The selective P-TEFb inhibitor CAN508 targets angiogenesis.', EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol. 46, no. 9, pp. 428-494. https://doi.org/10.1016/j.ejmech.2011.06.035

The selective P-TEFb inhibitor CAN508 targets angiogenesis. / Kryštof, Vladimír; Rárová, Lucie; Liebl, Johanna et al.
In: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , Vol. 46, No. 9, 2011, p. 428-494.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - The selective P-TEFb inhibitor CAN508 targets angiogenesis.

AU - Kryštof, Vladimír

AU - Rárová, Lucie

AU - Liebl, Johanna

AU - Zahler, Stefan

AU - Jorda, Radek

AU - Voller, Jiří

AU - Cankař, Petr

PY - 2011

Y1 - 2011

KW - ENDOTHELIAL GROWTH-FACTOR

KW - I-KAPPA-B

KW - KINASE INHIBITOR

KW - CELL-MIGRATION

KW - CYCLIN D1

KW - FACTOR EXPRESSION

KW - CANCER-THERAPY

KW - P53

KW - ROSCOVITINE

KW - FLAVOPIRIDOL

U2 - 10.1016/j.ejmech.2011.06.035

DO - 10.1016/j.ejmech.2011.06.035

M3 - Original Article

C2 - 21777997

SN - 0223-5234

VL - 46

SP - 428

EP - 494

JO - EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

JF - EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IS - 9

ER -

Kryštof V, Rárová L, Liebl J, Zahler S, Jorda R, Voller J et al. The selective P-TEFb inhibitor CAN508 targets angiogenesis. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY . 2011;46(9):428-494. doi: 10.1016/j.ejmech.2011.06.035